Corvus Pharmaceuticals(CRVS) - 2023 Q4 - Annual Report

Table of Contents (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Delaware 001-37719 46-4670809 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification Number) Securities registered pursuant to Section 12(g) of the Act: None DOCUMENTS INCORPORATED BY REFERENCE Table of Contents ...